Completed
Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
NCT05706038
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +3 more
- Locations
-
- Irccs Ospedale San Raffaele Milan, Italy